Early experimental tests have shown complete eradication of cancerous tumors in the implementation of CICD
Orange County, CA - August 30th 2017 - Early experimental tests have shown complete eradication of cancerous tumors in the implementation of a method known as Caspase Independent Cell Death (CICD). Dr Stephen Tait, who led the University of Glasgow research team into CICD, said the new method "often led to complete tumor regression" and "may be a more effective way to treat cancer" than the current technique, apoptosis. CICD also carries the lowest risk of cancer recurrence.Apoptosis is the most common cancer treatment consisting of chemotherapy, radiation, and newer immunotherapies. Apoptosis is a process that targets cancer cells triggered by normal body developments, usually as a defense mechanism during healing. This process also activates the release of proteins called caspases- protease enzymes that play essential roles in programmed cell death. This natural process tends to create minimal side effects, but this triggered cell death is “silent,” meaning no other bodily processes are triggered with it. The body relies on these other processes to fight off infection and provide bodily care while under apoptosis.
Due to the silent process, apoptosis can leave behind malignant cancer cells. These defects in treatment leave the body unarmed and susceptible to the metastasizing of tumors while becoming impervious to cancer drugs.
